BLUESTEIN R H & CO LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BLUESTEIN R H & CO LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$351,000
-19.3%
12,5000.0%0.02%
-18.5%
Q2 2022$435,000
-3.1%
12,5000.0%0.03%
+42.1%
Q1 2022$449,000
+54.3%
12,5000.0%0.02%
+90.0%
Q4 2021$291,000
+22.3%
12,5000.0%0.01%
+11.1%
Q3 2021$238,000
-5.6%
12,5000.0%0.01%
-10.0%
Q2 2021$252,000
+10.0%
12,5000.0%0.01%0.0%
Q1 2021$229,000
-8.8%
12,5000.0%0.01%
-9.1%
Q4 2020$251,000
-10.7%
12,500
-16.7%
0.01%
-21.4%
Q3 2020$281,000
-16.6%
15,0000.0%0.01%
-26.3%
Q2 2020$337,000
+51.1%
15,0000.0%0.02%0.0%
Q1 2020$223,000
-22.8%
15,0000.0%0.02%
+35.7%
Q4 2019$289,000
-2.7%
15,0000.0%0.01%
-17.6%
Q3 2019$297,000
-6.3%
15,0000.0%0.02%0.0%
Q2 2019$317,000
+3.6%
15,0000.0%0.02%0.0%
Q1 2019$306,000
+2.3%
15,0000.0%0.02%
-26.1%
Q4 2018$299,000
+3.5%
15,0000.0%0.02%
+64.3%
Q3 2018$289,000
+26.2%
15,0000.0%0.01%
+16.7%
Q2 2018$229,000
-18.5%
15,0000.0%0.01%
-20.0%
Q1 2018$281,000
-2.8%
15,0000.0%0.02%0.0%
Q4 2017$289,000
+7.8%
15,0000.0%0.02%0.0%
Q3 2017$268,0000.0%15,0000.0%0.02%
-6.2%
Q2 2017$268,000
-7.6%
15,000
-25.0%
0.02%
-5.9%
Q1 2017$290,000
-21.2%
20,0000.0%0.02%
-29.2%
Q4 2016$368,000
-2.9%
20,0000.0%0.02%
-4.0%
Q3 2016$379,000
+17.7%
20,0000.0%0.02%0.0%
Q2 2016$322,00020,0000.02%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders